Table 1. Clinical characteristics of the study subjects.
| Sex | Age at the time of the operation | Cause of the operation | Exposed AlloDerm size (mm) (Designed AlloDerm size(mm)) | Duration of the full conjunctivalisation | Follow up period | |
|---|---|---|---|---|---|---|
| Case 1 | M | 78 | AGV associated endophthalmitis | 7 × 7 (14 × 14) | Not fully yet. 4 × 4 mm remained. | 3 months |
| Case 2 | M | 50 | AGV associated endophthalmitis | 11 × 4 (20 × 11) | 6wk | 6 months |
| Case 3 | F | 32 | PEG associated inflammation | 8 × 4 (not recorded) | 6wk | 10 months |
| Case 4 | F | 82 | Endogenous endophthalmitis | 15 × 5 (not recorded) | Incomplete. 8 × 4 mm remained. | 6 months |
| Case 5 | M | 71 | Endogenous endophthalmitis | 12 × 8 (not recorded) | 18wk | 6 months |
| Case 6 | M | 70 | AGV associated endophthalmitis | 8.5 × 5 (not recorded) | 16wk | 12 months |
| Average | – | 63.8 | – | 10.3 × 5.5 (–) | – | 7.2 months |
Abbreviations: AGV, Ahmed glaucoma valve; F, female; M, male; PEG, polyethylene glycol.